Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 3.10B | 2.33B | 2.30B | 1.46B | 1.02B |
Gross Profit | 71.64M | 148.80M | 285.51M | 142.80M | 91.41M |
EBITDA | 77.03M | 163.47M | 266.82M | 176.34M | 113.14M |
Net Income | -16.04M | 54.92M | 121.38M | 59.14M | 24.48M |
Balance Sheet | |||||
Total Assets | 1.68B | 1.66B | 1.06B | 971.94M | 969.90M |
Cash, Cash Equivalents and Short-Term Investments | 352.62M | 300.71M | 106.16M | 73.03M | 78.34M |
Total Debt | 338.27M | 262.97M | 219.16M | 96.89M | 125.83M |
Total Liabilities | 584.85M | 535.95M | 334.98M | 400.14M | 447.76M |
Stockholders Equity | 985.37M | 1.02B | 573.79M | 457.93M | 400.56M |
Cash Flow | |||||
Free Cash Flow | 13.82M | -43.95M | 199.74M | 44.27M | -21.69M |
Operating Cash Flow | 96.86M | 104.46M | 318.82M | 94.88M | 50.62M |
Investing Cash Flow | -268.86M | -71.06M | -150.12M | -59.21M | -72.31M |
Financing Cash Flow | 2.49M | 204.95M | -133.45M | -40.95M | 20.11M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | 1.02B | 8.04 | 2.56% | 8.24% | -5.37% | 25.20% | |
68 Neutral | 218.40M | 12.50 | 0.00% | 2.20% | 29.04% | -1.55% | |
52 Neutral | 7.33 | -6.64% | 4.94% | 2.76% | -293.57% | ||
52 Neutral | 771.20M | -26.58 | -1.20% | 5.41% | 0.37% | -331.54% | |
48 Neutral | 616.30M | -17.73 | -9.30% | ― | 0.35% | -153.95% | |
41 Neutral | 62.77M | -0.05 | 16.58% | ― | -15.10% | 31.07% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. reported its interim financial results for the first half of 2025, showing a revenue of RMB1,442.2 million and a loss attributable to owners of RMB20.2 million. The company experienced a decline in gross profit and a net loss for the period, indicating challenges in maintaining profitability amidst market conditions.
The most recent analyst rating on (HK:2502) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Henan Jinyuan Hydrogenated Chemicals Co., Ltd. Class H stock, see the HK:2502 Stock Forecast page.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that it has settled all relevant consumption taxes with the tax authorities by the end of June 2025, which were already accounted for in its 2024 financial results. Consequently, there is no financial impact on the company’s results for the first half of 2025. The company has significantly reduced its production and sales of non-aromatic hydrocarbons in the first half of 2025, anticipating a decrease in sales for the entire year compared to 2024, thus minimizing the financial impact of the consumption tax.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has issued a profit warning, indicating an expected loss of approximately RMB20.1 million for the first half of 2025. This downturn is attributed to a reduction in the gross profit margin of its main product, hydrogenated benzene-based chemicals, due to a price decrease that outpaced the reduction in raw material costs. The company advises caution for shareholders and potential investors as the financial results are yet to be finalized and audited.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. has announced a board meeting scheduled for August 26, 2025, to discuss and potentially approve the unaudited interim results for the first half of 2025 and consider the payment of an interim dividend. This meeting could have significant implications for the company’s financial performance and shareholder returns, as it will address key financial results and potential dividend distributions.
Henan Jinyuan Hydrogenated Chemicals Co., Ltd. announced that there is no change in the shareholding of its controlling shareholder, Jinma Energy. Despite a termination notice served by Jinma Coking to Beijing Weigang regarding the sale of shares, Jinma Energy remains under the control of Mr. Yiu. This development is not expected to have any material impact on the financial position or operations of the company.